BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khare T, Palakurthi SS, Shah BM, Palakurthi S, Khare S. Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E3956. [PMID: 32486445 DOI: 10.3390/ijms21113956] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Melim C, Magalhães M, Santos AC, Campos EJ, Cabral C. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade. Expert Opin Drug Deliv 2022. [PMID: 35166619 DOI: 10.1080/17425247.2022.2041599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shah BM, Palakurthi SS, Khare T, Khare S, Palakurthi S. Natural proteins and polysaccharides in the development of micro/nano delivery systems for the treatment of inflammatory bowel disease. Int J Biol Macromol 2020;165:722-37. [PMID: 33010274 DOI: 10.1016/j.ijbiomac.2020.09.214] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Barani M, Rahdar A, Sargazi S, Amiri MS, Sharma PK, Bhalla N. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment. Sensing and Bio-Sensing Research 2021;32:100417. [DOI: 10.1016/j.sbsr.2021.100417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
4 Rahiman N, Markina YV, Kesharwani P, Johnston TP, Sahebkar A. Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases. J Control Release 2022;348:264-86. [PMID: 35649486 DOI: 10.1016/j.jconrel.2022.05.046] [Reference Citation Analysis]
5 Basha NJ, Basavarajaiah SM, Baskaran S, Kumar P. A comprehensive insight on the biological potential of embelin and its derivatives. Nat Prod Res 2021;:1-15. [PMID: 34304655 DOI: 10.1080/14786419.2021.1955361] [Reference Citation Analysis]
6 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
7 Chen F, Liu Q, Xiong Y, Xu L. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. Int J Nanomedicine 2021;16:4225-37. [PMID: 34188471 DOI: 10.2147/IJN.S310952] [Reference Citation Analysis]
8 Fan W, Zhang S, Wu Y, Lu T, Liu J, Cao X, Liu S, Yan L, Shi X, Liu G, Huang C, Song S. Genistein-Derived ROS-Responsive Nanoparticles Relieve Colitis by Regulating Mucosal Homeostasis. ACS Appl Mater Interfaces 2021;13:40249-66. [PMID: 34424682 DOI: 10.1021/acsami.1c09215] [Reference Citation Analysis]
9 Dos Santos AM, Carvalho SG, Meneguin AB, Sábio RM, Gremião MPD, Chorilli M. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release 2021;334:353-66. [PMID: 33901582 DOI: 10.1016/j.jconrel.2021.04.026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:11682. [PMID: 34769112 DOI: 10.3390/ijms222111682] [Reference Citation Analysis]
11 Placha D, Jampilek J. Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems. Pharmaceutics 2021;13:64. [PMID: 33419176 DOI: 10.3390/pharmaceutics13010064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
12 Lama S, Merlin-Zhang O, Yang C. In Vitro and In Vivo Models for Evaluating the Oral Toxicity of Nanomedicines. Nanomaterials (Basel) 2020;10:E2177. [PMID: 33142878 DOI: 10.3390/nano10112177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Quispe C, Cruz-Martins N, Manca ML, Manconi M, Sytar O, Hudz N, Shanaida M, Kumar M, Taheri Y, Martorell M, Sharifi-Rad J, Pintus G, Cho WC. Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases. Oxid Med Cell Longev 2021;2021:3149223. [PMID: 34584616 DOI: 10.1155/2021/3149223] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]